News
Mankind Pharma consolidated net profit declines 21.72% in the September 2025 quarter
06-Nov-2025 | 18:13
Sales rise 20.77% to Rs 3697.16 crore
Net profit of Mankind Pharma declined 21.72% to Rs 511.51 crore in the quarter ended September 2025 as against Rs 653.47 crore during the previous quarter ended September 2024. Sales rose 20.77% to Rs 3697.16 crore in the quarter ended September 2025 as against Rs 3061.43 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 3697.16 | 3061.43 | 21 |
| OPM % | 24.92 | 27.67 | - |
| PBDT | 845.84 | 951.72 | -11 |
| PBT | 624.02 | 851.23 | -27 |
| NP | 511.51 | 653.47 | -22 |
Powered by Capital Market - Live News